News
Molecular Imaging News
September 29, 2004
IAEA Publishes Technical Report on 99mTc Agents for CNS Imaging
IAEA
The International Atomic Energy Agency has just published Technical Report Series No: 496, "Development of 99mTc Agents for Imaging Central Neural Systems Receptors."
"Radiopharmaceuticals for imaging the receptors in the brain are of great interest in the management of several receptor related diseases such as epilepsy, Alzheimer's disease, Parkinson's disease and depression and other psychiatric disorders," the agency stated. "Technetium-99m is the ideal radioisotope for imaging, due to its low cost, its easy and universal availability through commercially available generator systems, and its physical decay characteristics. The IAEA organized a coordinated research program (CNP) aimed at the development of Technetium-99m central neural system receptor imaging agents.
"This report summarizes the work carried out by different research groups during the CRP. The research projects presented by the participants include the development and evaluation of serotonine receptor ligands, benzodiazepinic receptor ligands, dopamine receptor ligands, and the study of novel cores for Technetium-99m labeling, as well as molecular modeling."
The 198-page report may be downloaded in PDF format from the IAEA website at the link below.
The International Atomic Energy Agency has just published Technical Report Series No: 496, "Development of 99mTc Agents for Imaging Central Neural Systems Receptors."
"Radiopharmaceuticals for imaging the receptors in the brain are of great interest in the management of several receptor related diseases such as epilepsy, Alzheimer's disease, Parkinson's disease and depression and other psychiatric disorders," the agency stated. "Technetium-99m is the ideal radioisotope for imaging, due to its low cost, its easy and universal availability through commercially available generator systems, and its physical decay characteristics. The IAEA organized a coordinated research program (CNP) aimed at the development of Technetium-99m central neural system receptor imaging agents.
"This report summarizes the work carried out by different research groups during the CRP. The research projects presented by the participants include the development and evaluation of serotonine receptor ligands, benzodiazepinic receptor ligands, dopamine receptor ligands, and the study of novel cores for Technetium-99m labeling, as well as molecular modeling."
The 198-page report may be downloaded in PDF format from the IAEA website at the link below.
